Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsIndustry lead sponsorIndustry collaboratorPhase 1

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

AZD6714 / AstraZeneca

NCT00886366: Single Ascending Dose Study With Healthy Male Volunteers and Type II Diabetic Patients

Terminated

Europe

AZD6714, Placebo

AstraZeneca

Type 2 Diabetes

09/09

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites